WHO expects assessment of Moderna and two Chinese vaccines by end of next week
China has already deployed millions of doses of both its main vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa. So far, the WHO has given emergency use listing to three shots against COVID-19, made by Pfizer, AstraZeneca and Johnson & Johnson.
The World Health Organization expects to release its assessments for emergency use listing of the two main Chinese vaccines for COVID-19 as well as the Moderna shot by the end of next week, WHO Assistant Director-General Mariangela Simao said on Friday.
Simao said the WHO's independent panel was assessing the Moderna vaccine and a vaccine from China's Sinopharm on Friday and was due to look at China's other main vaccine, made by Sinovac Biotech, next week. "So, by the beginning of next week or the end of next week we will have the final assessment of these three vaccines out," she told a briefing.
WHO emergency use listing is a signal to national regulators that a vaccine is safe and effective, and would allow those vaccines to be bought and distributed by COVAX, the international programme to share vaccines for poor countries. Simao said it was important to have more vaccines available because of supply problems for other shots, including from India, a main source of vaccines for COVAX which has restricted exports because of a surge in domestic cases.
If approved, China's two vaccines would be the first developed in a non-Western country to receive the WHO's backing. China has already deployed millions of doses of both its main vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa.
So far, the WHO has given emergency use listing to three shots against COVID-19, made by Pfizer, AstraZeneca and Johnson & Johnson.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
India US partnership reaches unprecedented levels: Sullivan.
India, Luxembourg hold second round of foreign office consultations in Delhi
India's nominee Jagjit Pavadia re-elected to International Narcotics Control Board
India, Luxembourg hold second round of foreign office consulations in Delhi
India, Kazakhstan assess security challenges, exchange views on cross-border terrorism in South Asia